Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Hejian Pharmaceutical
Hangzhou, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
This profile describes 'Hangzhou Hejian Pharmaceutical', for which no direct public record exists. All presented information, including pipeline details, modalities, and therapeutic areas, is inferred from the closely named and active company, 'Hangzhou Hezheng Pharmaceutical Co., Ltd.', which specializes in innovative oncology and hematology drugs leveraging small molecule, PROTAC, ADC, and molecular glue technologies across various clinical stages.
- Therapeutic areas
- HematologyOncology
- Modalities
- Small moleculeProteolysis-targeting chimera therapyAntibody-drug conjugateMolecular glue
- Industry
- Biotech
Beyond the preview
Go deeper on Hangzhou Hejian Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Hejian Pharmaceutical.